<code id='2B8992A343'></code><style id='2B8992A343'></style>
    • <acronym id='2B8992A343'></acronym>
      <center id='2B8992A343'><center id='2B8992A343'><tfoot id='2B8992A343'></tfoot></center><abbr id='2B8992A343'><dir id='2B8992A343'><tfoot id='2B8992A343'></tfoot><noframes id='2B8992A343'>

    • <optgroup id='2B8992A343'><strike id='2B8992A343'><sup id='2B8992A343'></sup></strike><code id='2B8992A343'></code></optgroup>
        1. <b id='2B8992A343'><label id='2B8992A343'><select id='2B8992A343'><dt id='2B8992A343'><span id='2B8992A343'></span></dt></select></label></b><u id='2B8992A343'></u>
          <i id='2B8992A343'><strike id='2B8992A343'><tt id='2B8992A343'><pre id='2B8992A343'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:7
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Structure Therapeutics oral GLP
          Structure Therapeutics oral GLP

          DrewAngerer/GettyImagesStructureTherapeuticsreportedMondaythatitsoralGLP-1drugledtoweightlossintwosm

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          The biotech scorecard for the 2nd quarter: 12 industry events to watch

          APStockIntroducingSTAT’sBiotechQ2Scorecard,ouremoji-enabledmeansoftracking12make-or-breakeventsexpec